KPIs & Operating Metrics(New)
Biologics And Drug Delivery Revenue By CategoryBiologics And Drug Delivery Revenue By Category AnnualBreakdown Of AssetsCapital Equipment And Software Revenue By CategoryCapital Equipment And Software Revenue By Category AnnualCost Of RevenueDeferred RevenueEmployee StatisticsFunctional Neurosurgery Navigation And Therapy Revenue By CategoryFunctional Neurosurgery Navigation And Therapy Revenue By Category AnnualGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment, Net BreakdownRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Service LineRevenue By Service Line %Revenue By Service Line AnnualRevenue By Service Line Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Gross Profit (2018 - 2025)

Historic Gross Profit for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $5.6 million.

  • ClearPoint Neuro's Gross Profit rose 1553.54% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.0 million, marking a year-over-year increase of 1457.03%. This contributed to the annual value of $19.1 million for FY2024, which is 4045.84% up from last year.
  • As of Q3 2025, ClearPoint Neuro's Gross Profit stood at $5.6 million, which was up 1553.54% from $5.6 million recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Gross Profit peaked at $5.6 million during Q3 2025, and registered a low of $2.3 million during Q2 2021.
  • In the last 5 years, ClearPoint Neuro's Gross Profit had a median value of $3.4 million in 2022 and averaged $3.9 million.
  • Its Gross Profit has fluctuated over the past 5 years, first tumbled by 1103.56% in 2023, then soared by 5956.49% in 2024.
  • Over the past 5 years, ClearPoint Neuro's Gross Profit (Quarter) stood at $3.2 million in 2021, then increased by 5.72% to $3.4 million in 2022, then grew by 19.22% to $4.0 million in 2023, then rose by 18.66% to $4.8 million in 2024, then rose by 17.6% to $5.6 million in 2025.
  • Its last three reported values are $5.6 million in Q3 2025, $5.6 million for Q2 2025, and $5.1 million during Q1 2025.